The board of directors of pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday declared a dividend of USD1.50 per share of common stock for the second quarter of 2025.
This amount is unchanged from the first quarter.
Shareholders of record at the close of business on 16 May 2025 will receive the dividend on 10 June 2025.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government